Nature Reviews Clinical Oncology

2.3k papers and 172.7k indexed citations i.

About

The 2.3k papers published in Nature Reviews Clinical Oncology in the last decades have received a total of 172.7k indexed citations. Papers published in Nature Reviews Clinical Oncology usually cover Oncology (1.2k papers), Pulmonary and Respiratory Medicine (653 papers) and Molecular Biology (543 papers) specifically the topics of Cancer Genomics and Diagnostics (345 papers), Cancer Immunotherapy and Biomarkers (249 papers) and Lung Cancer Treatments and Mutations (249 papers). The most active scholars publishing in Nature Reviews Clinical Oncology are Diana Romero, Guido Kroemer, David Killock, Peter Sidaway and Klaus Pantel.

In The Last Decade

Fields of papers published in Nature Reviews Clinical Oncology

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Nature Reviews Clinical Oncology. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Nature Reviews Clinical Oncology

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Nature Reviews Clinical Oncology. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Nature Reviews Clinical Oncology with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025